Dong-A Socio Holdings Subsidiary BTIGEN Amends Manufacturing Contract with Alteogen Increasing Amount by 2.2 Billion Won - Limited Market Impact
Dong-A Socio Holdings subsidiary BTIGEN filed an amendment to its contract manufacturing agreement with Alteogen Inc., increasing the contract amount from 6.64 billion won to 8.84 billion won due to additional batch orders.
The amendment also reflects the name change of the subsidiary from ST Gen Bio to BTIGEN effective May 1 2026.
The incremental contract value of 2.2 billion won represents less than 0.4% of Dong-A Socio Holdings' market capitalization, resulting in a negligible financial impact.
[AI Summary]The contract amount increase for Dong-A Socio Holdings subsidiary BTIGEN is minor and neutral to the stock price and financial structure, with no changes to existing contract terms or counterparty credibility.
KOSPI Filing Information
[Correction of Description] Conclusion of Single Sales and Supply Contract (Major Management Matters of Subsidiary)